aspirin and hydroxyurea

aspirin has been researched along with hydroxyurea in 156 studies

Research

Studies (156)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (3.21)	18.7374
1990's	27 (17.31)	18.2507
2000's	52 (33.33)	29.6817
2010's	56 (35.90)	24.3611
2020's	16 (10.26)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Kim, DN; Kwak, YS; Lee, KT	1
Adlakha, A; Bechard, DL; Geer, MR	1
Campbell, KM; Schubert, DS	1
Boswell, VD; Datta, MC; Dowla, HA; Srivastava, KK; Washington, I	1
Clark, P; Goldstein, R; Gonwa, T; Husberg, B; Klintmalm, G; Stone, M	1
Datta, MC; Dowla, HA; Spears, HJ	1
Kwiatkowska, J; Malec, J; Przybyszewski, WM; Sitarska, E; Szczepańnska, I	1
DePass, LR; Weaver, EV	1
Bauernfeind, RA; Bauman, JL; Hartsough, N; Hasegawa, GR; Roden, R; Shulruff, S	1
Mughal, TI	1
Michiels, JJ; Van Genderen, PJ	1
Chan, TC; Knapp, DW; Kuczek, T; Park, B; Reagan, WJ	1
Fuse, I	1
Barbui, T; Cortelazzo, S; Finazzi, G; Galli, M; Rodeghiero, F; Ruggeri, M; Vestri, O	1
Callery, JC; Cohn, J; Drazen, JM; Fischer, AR; Igarashi, Y; Kaliner, MA; Lilly, CM; Rosenberg, MA; Rubin, P; White, MV	1
Fernandez, H	1
Callery, JC; Cohn, J; Drazen, JM; Fischer, AR; Israel, E; Lilly, CM; Rosenberg, MA; Rubin, P; Shapiro, J	1
Townsend-Pico, W; Yoshizumi, MO	1
Ganey, PE; Peters-Golden, M; Schiamberg, E; Tithof, PK	1
Griesshammer, M; Heimpel, H; Pearson, TC	1
Dapling, RB; Greaves, M; Nelson, ME; Snowden, JA; Talbot, JF; West, J	1
Catalano, D; Dell'Isola, A; Di Rosa, G	1
Leenknegt, H; Michiels, JJ; van Genderen, PJ	1
Berlin, NI; Wasserman, LR	1
Bochenek, G; Boodhoo, TI; Dahlén, B; Dahlén, SE; Dubé, LM; Kumlin, M; Mastalerz, L; Nizankowska, E; Pinis, G; Swanson, LJ; Szczeklik, A; Wright, S; Zetterström, O	1
Girolami, A; Randi, ML; Rinaldi, V; Rossi, C; Zerbinati, P	1
Castonguay, A; Rioux, N	1
Ellis, MH	1
Bruserud, O; Knutsen, H	1
Silverstein, MN; Tefferi, A	1
Fabris, F; Girolami, A; Menapace, L; Randi, ML; Rossi, C	1
Fabris, F; Girolami, A; Randi, ML; Rossi, C	1
Green, AR	1
Lang, DM	1
Daffern, PJ; Pauls, JD; Simon, RA; Stevenson, DD	1
Brière, J	1
Briere, J; Guilmin, F	1
Agha, S; Cleary, JP; Fang, M; Lee, R; Lockridge, L; Mazur, EM	1
Bangerter, M; Griesshammer, M; Grünewald, M	1
Tefferi, A; Wright, CA	1
Rezaei Kalantari, H	1
Atabay, B; Oniz, H; Ozer, EA; Turker, M; Yaprak, I	1
Devendra, K; Koh, LP; Tien, SL	1
Solberg, LA	1
Cooper, B; Goldstein, RM; Klintmalm, GB; Levy, MF; Melear, JM; Molmenti, EP; Netto, GJ; Stone, MJ	1
Griesshammer, M; Langer, C	1
Schafer, AI	1
Fiorucci, S; Hollenberg, MD; von der Weid, PY; Wallace, JL	1
Beillat, T; Dreyfus, M; Macro, M	1
Elliott, MA; Tefferi, A	1
Bareford, D; Buck, G; Campbell, PJ; East, CL; Green, AR; Grigg, AP; Harrison, CN; Reilly, JT; Revell, P; van der Walt, JD; Wheatley, K; Wilkins, BS; Woodcock, BE	1
Barbui, T; Finazzi, G	2
Costello, R; O'Callaghan, T; Sébahoun, G	1
Tefferi, A	2
Barbieri, C; Capello, D; Cerri, M; Conconi, A; Cortini, F; Deambrogi, C; Franceschetti, S; Gaidano, G; Rossi, D	1
Konkle, B; Lankipalli, R; Mohler, ER	1
Petrides, PE	2
Gisslinger, H	1
Silver, RT	1
Ludington, E; Mehra, P; Simon, RA; Stevenson, DD; White, A	1
Arndt, CA; Jensen, AW; Tefferi, A	1
Niazi, M; Robins, EB	1
Idetsuki, T; Igarashi, A; Iki, S; Kida, M; Nakasone, H; Oseto, K; Shinhori, H; Taoka, K; Urabe, M; Usukine, K	1
Reilly, JT	1
Bareford, D; Buck, G; Campbell, PJ; East, CL; Erber, WN; Green, AR; Harrison, CN; Paul, B; Wheatley, K; Wilkins, BS	1
McLornan, D; McMullin, M	1
Cacciola, E; Cacciola, RR; Di Francesco, E; Giustolisi, R; Pezzella, F; Tibullo, D	1
Di Gennaro, L; Landolfi, R	1
Aydoğdu, S; Diker, E; Gökaslan, S; Tekin, M	1
Gangat, N; Tefferi, A	1
Birgegård, G	1
Bildirici, U; Celikyurt, U; Ural, E	1
Arisaka, O; Endoh, K; Fukushima, K; Hagisawa, S; Hayashi, Y; Kubota, T; Kurosawa, H; Kuwashima, S; Matsushita, T; Okada, Y; Okuya, M; Park, MJ; Sato, Y; Sugita, K	1
Passamonti, F; Tefferi, A	1
Chojnowski, K; Robak, T; Smolewski, P; Treliński, J; Tybura, M	1
Beer, PA; Green, AR	1
Demulder, AC; Malarme, M; Mesquita, Mdo C; Noubouossie, D; Sol, EB	1
Finotto, S; Fortuna, S; Rodeghiero, F; Ruggeri, M	1
Erbel, R; Kälsch, H; Wieneke, H	1
Mannucci, PM	1
Burkemper, NM; Frater, JL; Hurley, MY; Prodanovic, EM	1
Ayvaz, OC; Bolaman, Z; Bozkurt, G; Kadikoylu, G; Yavasoglu, I	1
Chinnakotla, S; Davis, GL; Goldstein, RM; Kim, P; Klintmalm, E; Klintmalm, GB; Landaverde, C; Levy, MF; Saad, R; Stone, MJ; Tomiyama, K; Trotter, JF	1
Chondropoulos, S; Dervenoulas, J; Kapsimali, V; Kopterides, P; Mantzios, G; Nikolopoulos, GK; Tsantes, AE; Tsirigotis, P; Zoi, K; Zomas, A	1
Cherian, SV; Das, S; Gajra, A; Garcha, AS; Jasti, S; Karachiwala, H	1
Belotti, A; Elli, E; Lanzi, E; Pioltelli, P; Pogliani, E; Speranza, T	1
Barbui, T	1
Dowson, A; Frewin, R	1
Dua, V; Kumar, V; Sachdeva, A; Saxena, R; Yadav, SP	1
Bakhteeva, TD; Kalinkina, NV; Skliannaia, EV; Taradin, GG; Vatutin, NT	1
Lengfelder, E	1
Frucht, SJ; Hoffman, R; Kremyanskaya, M; Lew, J; Mascarenhas, J	1
Bain, BJ; Deplano, S; Garnett, C; Kanfer, E; Naresh, K	1
Geyer, H; Hensley, B; Mesa, R	1
Alvarez-Larrán, A; Besses, C; Cervantes, F	1
Haznedaroglu, IC	1
Balduini, CL; Boveri, E; Croci, G; Pecci, A	1
Jin, L; Ling, C; Zhu, GH	1
Akalin, I; Alver, A; Durmus, A; Mentese, A; Sumer, A; Topal, C; Yilmaz, M	1
Miyamoto, T; Yoshimoto, G	1
Barbui, T; Tefferi, A	4
Barbui, T; Carobbio, A; Finazzi, G; Gisslinger, H; Pardanani, A; Passamonti, F; Pieri, L; Rambaldi, A; Randi, ML; Rodeghiero, F; Rumi, E; Tefferi, A; Thiele, J; Vannucchi, AM	1
Hoffman, R; Kremyanskaya, M; Mascarenhas, J	1
Basso, M; De Cristofaro, R; Dragani, A; Lancellotti, S; Petrucci, G; Ranalli, P; Rocca, B; Tartaglione, R	1
Aumiller, J	1
Abboud, CN; Adler, K; Berenzon, D; Heaney, ML; Hobbs, GS; Hoffman, R; Jabbour, EJ; Komrokji, RS; Kremyanskaya, M; Mascarenhas, J; Moliterno, AR; Oh, ST; Rampal, RK; Rice, L; Ritchie, EK; Stein, BL	1
Al-Dewik, N; Carillo, S; Cassinat, B; Chauveau, A; Chomienne, C; Dosquet, C; Giraudier, S; Ianotto, JC; Kiladjian, JJ; Legouffe, E; Schlageter, MH; Ugo, V; Verger, E; Yassin, MA	1
Dennis, EA; Mouchlis, VD	1
Harrison, C; Reiter, A	1
Fujimura, K; Shimazu, Y	1
Demeter, J; Dombi, P; Egyed, M; Homor, L; Illés, Á; Karadi, E; Simon, Z; Udvardy, M	1
Fujimoto, M; Inoue, S; Kessoku, R; Okiyama, N; Okune, M; Shiraki, N	1
Corvetta, D; Di Pierro, AM; Eakins, E; Feistritzer, C; Gambato, R; Gastl, G; Gherlinzoni, F; Gottardi, M; Krampera, M; Langes, M; Marcheselli, L; Mazzoleni, G; Mega, A; Murphy, C; Pacquola, E; Perbellini, O; Piccin, A; Piva, E; Plebani, M; Pusceddu, I; Steurer, M; Tauber, M; Van Schilfgaarde, M; Veneri, D	1
Domon, H; Isono, T; Kawabata, S; Kurosawa, M; Maekawa, T; Oda, M; Terao, Y; Yamaguchi, M	1
Usui, N	1
Buck, G; Campbell, PJ; Cook, J; Forsyth, C; Godfrey, AL; Green, AR; Grinfeld, J; Harrison, CN; Kiladjian, JJ; MacLean, C; McMullin, MF; Nangalia, J; Temple, J; Wheatley, K; Wilkins, BS	1
Berchie, PO; Opare-Sem, OK; Ovbiagele, B; Sarfo, FS	1
Besses, C; Griesshammer, M; Kiladjian, JJ	1
Bertozzi, I; Putti, MC; Randi, ML	1
Butterfield, J; Castells, M	1
Boucher, AA; Gurunathan, A; Quinn, CT; Ricci, KW; Taylor, JM; Vadivelu, S	1
Adams, KN; Ebert, CS; Farquhar, DR; Lee, SE; Masood, MM; Senior, BA; Thorp, BD; Zanation, AM	1
Bolaman, AZ; Yavaşoǧlu, İ	1
Demeter, J; Dombi, P; Egyed, M; Ercsei, I; Gasztonyi, Z; Gy Korom, V; Herczeg, J; Homor, L; Illes, A; Karadi, E; Kellner, A; Simon, Z; Szerafin, L; Udvardy, M	1
Jain, M; Kumar, N; Tripathi, AK; Verma, SP	1
Edahiro, Y	2
Kimura, F; Okada, Y	1
Antonioli, E; Guglielmelli, P; Loscocco, GG; Mannelli, F; Romano, I; Rotunno, G; Vannucchi, AM; Vergoni, F	1
Bang, SM; Choi, HS; Hong, J; Hwang, SM; Kim, SA; Lee, JH; Lee, JO; Lee, JY; Ma, Y	1
Crodel, CC; Heidel, FH; Jacobasch, L; Jentsch-Ullrich, K; Palandri, F; Reiser, M; Sauer, A; Tesch, H; Ulshöfer, T; Wunschel, R	1
Ajzenberg, N; Couturaud, F; Ianotto, JC; Lacut, K; Lippert, E; Nicol, C; Pan-Petesch, B	1
Grove, EL; Hvas, AM; Kristensen, SD; Ommen, HB; Pasalic, L; Pedersen, OB	1
Brazel, D; Pakbaz, Z; Runge, A	1
Mora, B; Passamonti, F	1
Akay, OM; Erdoğan Özünal, I; Göktürk, A; Kaya, AH; Koçak Göktürk, I; Öztürk, E; Yılmaz, G	1
Gadó, K; Khodier, M	1

Reviews

45 review(s) available for aspirin and hydroxyurea

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Primary thrombocythemia: a current perspective. Stem cells (Dayton, Ohio), 1995, Volume: 13, Issue:4 Topics: Aspirin; Diagnosis, Differential; Humans; Hydroxyurea; Interferon Type I; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Plateletpheresis; Quinazolines; Recombinant Proteins; Thrombocytosis	1995
Essential thrombocythemia and pregnancy. Leukemia & lymphoma, 1996, Volume: 22 Suppl 1 Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Aspirin; Busulfan; Combined Modality Therapy; Dipyridamole; Female; Fetal Death; Fetal Growth Retardation; Hemorrhage; Humans; Hydroxyurea; Infarction; Interferon-alpha; Placenta; Platelet Aggregation Inhibitors; Plateletpheresis; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombocythemia, Essential	1996
[A management program for primary thrombocytopenia]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1999, Sep-30, Volume: 119, Issue:23 Topics: Adult; Aged; Anticoagulants; Aspirin; Female; Guidelines as Topic; Humans; Hydroxyurea; Interferon Type I; Male; Middle Aged; Norway; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Recombinant Proteins; Regional Medical Programs; Risk Factors; Societies, Medical; Thrombocythemia, Essential	1999
Treatment of polycythaemia vera and essential thrombocythaemia. Bailliere's clinical haematology, 1998, Volume: 11, Issue:4 Topics: Adult; Aged; Aspirin; Chlorambucil; Disease Progression; Female; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Quinazolines; Thrombocythemia, Essential; Thrombosis	1998
The pathogenesis and management of essential thrombocythaemia. Haematologica, 1999, Volume: 84 Suppl EHA-4 Topics: Acute Disease; Alkylating Agents; Aspirin; Cardiovascular Diseases; Clone Cells; Gene Expression; Hemorrhage; Humans; Hydroxyurea; Leukemia, Myeloid; Megakaryocytes; Platelet Aggregation Inhibitors; Quinazolines; Risk; Thrombocythemia, Essential; Thrombophilia	1999
Management of patients with essential thrombocythemia: current concepts and perspectives. Pathologie-biologie, 2001, Volume: 49, Issue:2 Topics: Adult; Aged; Aspirin; Case Management; Clinical Trials as Topic; Diagnosis, Differential; Disease Progression; Female; Hemorrhagic Disorders; Humans; Hydroxyurea; Interferons; Leukemia; Male; Middle Aged; Pipobroman; Platelet Aggregation Inhibitors; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Quinazolines; Risk; Safety; Thrombocythemia, Essential; Thrombophilia	2001
Current treatment practice for essential thrombocythaemia in adults. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:3 Topics: Adult; Aspirin; Humans; Hydroxyurea; Interferon-alpha; Pipobroman; Prognosis; Quinazolines; Thrombocythemia, Essential	2001
A single institutional experience with 43 pregnancies in essential thrombocythemia. European journal of haematology, 2001, Volume: 66, Issue:3 Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Aspirin; Busulfan; Erythromelalgia; Female; Fetal Death; Follow-Up Studies; Heparin; Humans; Hydroxyurea; Migraine Disorders; Obstetric Labor, Premature; Phosphorus Radioisotopes; Platelet Aggregation Inhibitors; Platelet Count; Plateletpheresis; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, First; Pregnancy, Ectopic; Pregnancy, High-Risk; Quinazolines; Retrospective Studies; Risk; Thrombocythemia, Essential; Uterine Hemorrhage	2001
[How I treat ... sickle cell anemia: current therapies]. Revue medicale de Liege, 2001, Volume: 56, Issue:10 Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antisickling Agents; Arginine; Aspirin; Blood Transfusion; Fluid Therapy; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Hydroxyurea; Nitric Oxide; Thromboembolism; Transplantation, Homologous	2001
Therapeutic options for essential thrombocythemia and polycythemia vera. Seminars in oncology, 2002, Volume: 29, Issue:3 Suppl 10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Busulfan; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Phosphorus Radioisotopes; Polycythemia Vera; Quinazolines; Risk Assessment; Thrombocytosis	2002
Pharmacotherapy of essential thrombocythaemia: economic considerations. Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:9 Topics: Age Factors; Antineoplastic Agents; Aspirin; Clinical Trials, Phase II as Topic; Cost-Benefit Analysis; Humans; Hydroxyurea; Interferon-alpha; Pipobroman; Quinazolines; Risk Factors; Thrombocythemia, Essential	2003
Thrombocytosis. The New England journal of medicine, 2004, Mar-18, Volume: 350, Issue:12 Topics: Aspirin; Clone Cells; Diagnosis, Differential; Humans; Hydroxyurea; Interferon-alpha; Plasmapheresis; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombocytosis	2004
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. British journal of haematology, 2005, Volume: 128, Issue:3 Topics: Aged; Aspirin; Hemorrhage; Humans; Hydroxyurea; Middle Aged; Polycythemia Vera; Risk Factors; Thrombocythemia, Essential; Thrombosis	2005
[Treatment of essential thrombocythemia]. La Revue de medecine interne, 2005, Volume: 26, Issue:12 Topics: Aspirin; Enzyme Inhibitors; Hemorrhage; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Platelet Aggregation Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Risk Factors; Thrombocythemia, Essential	2005
Essential thrombocythemia: scientific advances and current practice. Current opinion in hematology, 2006, Volume: 13, Issue:2 Topics: Antineoplastic Agents; Aspirin; Bone Marrow Examination; Humans; Hydroxyurea; In Situ Hybridization, Fluorescence; Janus Kinase 2; Platelet Aggregation Inhibitors; Point Mutation; Thrombocythemia, Essential; Thrombosis	2006
Anagrelide: what was new in 2004 and 2005? Seminars in thrombosis and hemostasis, 2006, Volume: 32, Issue:4 Pt 2 Topics: Antineoplastic Agents; Aspirin; Blood Platelets; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; History, 21st Century; Humans; Hydroxyurea; Male; Megakaryocytes; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Randomized Controlled Trials as Topic; Signal Transduction; Thrombocythemia, Essential	2006
Update on diagnosis and management of essential thrombocythemia. Seminars in thrombosis and hemostasis, 2006, Volume: 32, Issue:4 Pt 2 Topics: Age Factors; Antineoplastic Agents; Aspirin; Drug Antagonism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Life Expectancy; Male; Quinazolines; Risk Factors; Thrombocythemia, Essential	2006
Treatment of polycythemia vera. Seminars in thrombosis and hemostasis, 2006, Volume: 32, Issue:4 Pt 2 Topics: Antineoplastic Agents; Aspirin; Female; Humans; Hydroxyurea; Interferons; Janus Kinase 2; Leukemia; Male; Mutation; Phlebotomy; Polycythemia Vera; Protein-Tyrosine Kinases; Proto-Oncogene Proteins	2006
[Primary thrombocythemia: diagnosis and therapy]. Medizinische Klinik (Munich, Germany : 1983), 2006, Aug-15, Volume: 101, Issue:8 Topics: Adult; Aged; Aspirin; Child; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Male; Mutation; Platelet Aggregation Inhibitors; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Primary Prevention; Prospective Studies; Quinazolines; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Thrombocythemia, Essential; Time Factors	2006
How would I manage a case of essential thrombocythaemia presenting with an ischaemic toe. Hematological oncology, 2008, Volume: 26, Issue:1 Topics: Aspirin; Evidence-Based Medicine; Humans; Hydroxyurea; Interferon-alpha; Ischemia; Janus Kinase 2; Male; Middle Aged; Mutation; Risk; Thrombocythemia, Essential; Toes	2008
Pharmacotherapy of essential thrombocythemia. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:10 Topics: Age Factors; Antineoplastic Agents; Aspirin; Disease Progression; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Platelet Aggregation Inhibitors; Risk Factors; Thrombocythemia, Essential	2008
Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia, 2008, Volume: 22, Issue:8 Topics: Aspirin; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Mutation; Phlebotomy; Polycythemia Vera; Quinazolines; Risk Factors; Survival Analysis; Thrombocythemia, Essential	2008
Long-term management of thrombocytosis in essential thrombocythaemia. Annals of hematology, 2009, Volume: 88, Issue:1 Topics: Algorithms; Antineoplastic Agents; Aspirin; Female; Fibrinolytic Agents; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Pregnancy; PubMed; Quinazolines; Randomized Controlled Trials as Topic; Thrombocythemia, Essential; Thrombocytosis	2009
Pathogenesis and management of essential thrombocythemia. Hematology. American Society of Hematology. Education Program, 2009 Topics: Acute Disease; Aged; Aspirin; Clone Cells; Disease Management; Disease Progression; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Leukemia, Myeloid; Middle Aged; Models, Biological; Mutation, Missense; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Protein Kinase Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombophilia	2009
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. American journal of hematology, 2012, Volume: 87, Issue:3 Topics: Acute Disease; Age Factors; Alkylating Agents; Anticoagulants; Aspirin; Busulfan; Disease Management; Disease Progression; DNA Mutational Analysis; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Leukemia, Myeloid; Leukocyte Count; Phlebotomy; Polycythemia Vera; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Thrombocythemia, Essential; Thrombophilia; Thrombosis	2012
Headache in essential thrombocythaemia. International journal of clinical practice, 2012, Volume: 66, Issue:10 Topics: Alkylating Agents; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Headache Disorders; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Phosphorus Radioisotopes; Platelet Aggregation Inhibitors; Quinazolines; Radiopharmaceuticals; Risk Factors; Thrombocythemia, Essential	2012
[True polycythemia: current views of pathogenesis, diagnostics and treatment]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:8 Topics: Age Factors; Algorithms; Antineoplastic Agents; Aspirin; Benzamides; Combined Modality Therapy; Hematocrit; Hemodilution; Humans; Hydroxyurea; Imatinib Mesylate; Janus Kinase 2; Leukemia, Myeloid, Acute; Mutation; Piperazines; Platelet Aggregation Inhibitors; Polycythemia Vera; Prevalence; Primary Myelofibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Risk Assessment; Thrombosis; Treatment Outcome	2012
[Diagnosis and therapy of polycythemia vera in the era of JAK2]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:7 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diagnosis, Differential; DNA Mutational Analysis; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Phlebotomy; Point Mutation; Polycythemia Vera	2013
Polycythemia vera: current pharmacotherapy and future directions. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:5 Topics: Alkylating Agents; Aspirin; Hematocrit; Hematologic Agents; Hematopoiesis; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Nitriles; Polycythemia Vera; Polyethylene Glycols; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Recombinant Proteins; Risk Assessment; Risk Factors; Treatment Outcome	2013
[Treatment of essential thrombocythemia]. Medicina clinica, 2013, Sep-21, Volume: 141, Issue:6 Topics: Adult; Age Factors; Aged; Anticoagulants; Aspirin; Cell Transformation, Neoplastic; Disease Progression; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Intraoperative Complications; Janus Kinase 2; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mutation, Missense; Platelet Aggregation Inhibitors; Point Mutation; Pregnancy; Pregnancy Complications, Hematologic; Primary Myelofibrosis; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombophilia	2013
[Treatment strategy for myeloproliferative neoplasms]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10 Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Immunosuppressive Agents; Janus Kinase 2; Molecular Targeted Therapy; Mutation; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Receptors, Thrombopoietin; Thalidomide; Thrombocythemia, Essential	2014
Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. American journal of hematology, 2015, Volume: 90, Issue:2 Topics: Aspirin; Calreticulin; Diagnosis, Differential; Disease Management; Humans; Hydroxyurea; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Receptors, Thrombopoietin; Risk Factors; Survival Analysis; Thrombocythemia, Essential; Thrombocytosis	2015
Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:8 Topics: Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hydroxyurea; Interferon-alpha; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Polyethylene Glycols; Pyrazoles; Pyrimidines; Quinazolines	2015
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-20, Volume: 33, Issue:33 Topics: Aspirin; Clinical Trials, Phase II as Topic; Disease Progression; Female; Humans; Hydroxyurea; Incidence; Interferon-beta; Janus Kinase 2; Male; Phlebotomy; Point Mutation; Polycythemia Vera; Polyethylene Glycols; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome	2015
Membrane and inhibitor interactions of intracellular phospholipases A2. Advances in biological regulation, 2016, Volume: 61 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Cell Membrane; Eukaryotic Cells; Gene Expression Regulation; Humans; Hydroxyurea; Lipoxygenase; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Phospholipases A2; Phospholipids; Prostaglandin-Endoperoxide Synthases; Signal Transduction	2016
How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera. Current hematologic malignancy reports, 2016, Volume: 11, Issue:5 Topics: Antineoplastic Agents; Aspirin; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Nitriles; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Survival Rate	2016
Clinical and histological characteristics of livedo racemosa in essential thrombocythemia: A report of two cases and review of the published works. The Journal of dermatology, 2017, Volume: 44, Issue:1 Topics: Aged; Aspirin; Calreticulin; Humans; Hydroxyurea; Janus Kinase 2; Livedo Reticularis; Male; Middle Aged; Mutation; Platelet Aggregation Inhibitors; Platelet Count; Rare Diseases; Skin; Thrombocythemia, Essential	2017
Contemporary management of essential thrombocythemia in children. Expert review of hematology, 2019, Volume: 12, Issue:5 Topics: Anticoagulants; Aspirin; Calreticulin; Child; Disease Management; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Platelet Aggregation Inhibitors; Platelet Count; Protein Kinase Inhibitors; Receptors, Thrombopoietin; Thrombocythemia, Essential	2019
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management. The journal of allergy and clinical immunology. In practice, 2019, Volume: 7, Issue:4 Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cromolyn Sodium; Disease Management; Glucocorticoids; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyurea; Interleukin-6; Leukotriene Antagonists; Leukotriene E4; Mastocytosis; Omalizumab; Prostaglandin D2; Tryptases	2019
Essential Thrombocythemia Presenting with Recurrent Priapism: A Case Report and Review of Literature. The American journal of case reports, 2020, Jul-28, Volume: 21 Topics: Adult; Antineoplastic Agents; Aspirin; Cytoreduction Surgical Procedures; Humans; Hydroxyurea; Male; Platelet Aggregation Inhibitors; Priapism; Recurrence; Thrombocythemia, Essential	2020
Treatment options and pregnancy management for patients with PV and ET. International journal of hematology, 2022, Volume: 115, Issue:5 Topics: Aspirin; Female; Humans; Hydroxyurea; Janus Kinase 2; Janus Kinase Inhibitors; Myeloproliferative Disorders; Polycythemia Vera; Pregnancy; Thrombocythemia, Essential	2022
Stroke in sickle cell disease and the promise of recent disease modifying agents. Journal of the neurological sciences, 2022, 11-15, Volume: 442 Topics: Adult; Anemia, Sickle Cell; Anticoagulants; Aspirin; Cerebral Infarction; Humans; Hydroxyurea; Stroke; Ultrasonography, Doppler, Transcranial	2022
SOHO State of the Art Updates and Next Questions \| Polycythemia Vera: Is It Time to Rethink Treatment? Clinical lymphoma, myeloma & leukemia, 2023, Volume: 23, Issue:2 Topics: Aspirin; Humans; Hydroxyurea; Janus Kinase 2; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Thrombosis	2023
BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera. Physiology international, 2023, Sep-05, Volume: 110, Issue:3 Topics: Aspirin; Humans; Hydroxyurea; Mutation; Polycythemia Vera; Thrombocythemia, Essential	2023

Trials

13 trial(s) available for aspirin and hydroxyurea

Article	Year
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. The New England journal of medicine, 1995, Apr-27, Volume: 332, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Female; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk; Thrombocytosis; Thromboembolism; Ticlopidine	1995
Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. The Journal of allergy and clinical immunology, 1994, Volume: 94, Issue:6 Pt 1 Topics: Adult; Aspirin; Asthma; Blood Proteins; Chymases; Cross-Over Studies; Double-Blind Method; Eosinophil Granule Proteins; Female; Histamine; Humans; Hydroxyurea; Leukotrienes; Male; Mast Cells; Middle Aged; Nasal Mucosa; Ribonucleases; Serine Endopeptidases; Tryptases	1994
The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. The American review of respiratory disease, 1993, Volume: 148, Issue:6 Pt 1 Topics: Adult; Arachidonate 5-Lipoxygenase; Aspirin; Asthma; Bronchoconstriction; Double-Blind Method; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Hydroxyurea; Leukotriene E4; Lipoxygenase Inhibitors; Male; Middle Aged	1993
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:4 Pt 1 Topics: Adrenergic beta-Agonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Glucocorticoids; Histamine; Humans; Hydroxyurea; Leukotriene Antagonists; Leukotriene D4; Lipoxygenase Inhibitors; Male; Middle Aged; Peak Expiratory Flow Rate	1998
Aspirin seems as effective as myelosuppressive agents in the prevention of rethrombosis in essential thrombocythemia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999, Volume: 5, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Busulfan; Disease-Free Survival; Female; Hemorrhage; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Survival Rate; Thrombocythemia, Essential; Thrombosis	1999
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation, 2002, Oct-27, Volume: 74, Issue:8 Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Blood Coagulation Disorders; Budd-Chiari Syndrome; Enzyme Inhibitors; Factor V; Female; Follow-Up Studies; Humans; Hydroxyurea; Liver Transplantation; Male; Middle Aged; Mutation; Platelet Aggregation Inhibitors; Polycythemia Vera; Prothrombin; Sarcoidosis	2002
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Primary Myelofibrosis; Quinazolines; Thrombocythemia, Essential; Thrombosis	2005
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:5 Topics: Acetates; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Asthmatic Agents; Aspirin; Asthma; Cyclopropanes; Desensitization, Immunologic; Drug Hypersensitivity; Female; Forced Expiratory Volume; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Phenylcarbamates; Quinolines; Sulfides; Sulfonamides; Tosyl Compounds; Treatment Outcome	2006
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes. Blood, 2008, Jan-01, Volume: 111, Issue:1 Topics: Adult; Antineoplastic Agents; Aspirin; Biopsy; Blood Cell Count; Drug Therapy, Combination; Hematology; Humans; Hydroxyurea; Megakaryocytes; Observer Variation; Pathology, Clinical; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Quinazolines; Thrombocytosis	2008
Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia. Acta haematologica, 2007, Volume: 118, Issue:4 Topics: Adult; Aged; Antithrombin III; Aspirin; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Hemorrhage; Humans; Hydroxyurea; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Factor 4; Prothrombin; Quinazolines; Thrombocythemia, Essential; Thrombosis	2007
The influence of low-dose aspirin and hydroxyurea on platelet-leukocyte interactions in patients with essential thrombocythemia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Platelets; Case-Control Studies; Cell Communication; Female; Humans; Hydroxyurea; Leukocytes; Lymphocyte Activation; Male; Middle Aged; Neutrophils; Risk Assessment; Thrombocythemia, Essential; Thrombosis	2009
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 12-01, Volume: 36, Issue:34 Topics: Adult; Aspirin; Australia; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; France; Humans; Hydroxyurea; Internationality; Ireland; Janus Kinase 2; Kaplan-Meier Estimate; Male; Middle Aged; New Zealand; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Thrombocythemia, Essential; Thrombosis; Treatment Outcome; United Kingdom	2018
Thromboembolic events in polycythemia vera. Annals of hematology, 2019, Volume: 98, Issue:5 Topics: Age Factors; Anticoagulants; Aspirin; Humans; Hydroxyurea; Interferons; Nitriles; Phlebotomy; Polycythemia Vera; Pyrazoles; Pyrimidines; Risk Factors; Thromboembolism; Thrombosis	2019

Other Studies

98 other study(ies) available for aspirin and hydroxyurea

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Study of drugs affecting cholesterol-induced atherosclerosis in rabbits. Advances in experimental medicine and biology, 1976, Volume: 67, Issue:00 Topics: Animals; Arteriosclerosis; Aspirin; Chloroquine; Cholesterol, Dietary; Clomipramine; Hydroxyurea; Male; Mercaptopurine; Pharmacology; Pyridinolcarbamate; Rabbits; Sodium Dodecyl Sulfate	1976
Primary thrombocytosis and myocardial ischemic syndrome in a young woman. American heart journal, 1992, Volume: 123, Issue:3 Topics: Adult; Aspirin; Coronary Angiography; Coronary Disease; Electrocardiography; Female; Humans; Hydroxyurea; Platelet Count; Thrombocytosis	1992
Reversal of delirium associated with essential thrombocythemia by antiplatelet therapy. Psychosomatics, 1992,Spring, Volume: 33, Issue:2 Topics: Aged; Aspirin; Delirium; Female; Humans; Hydroxyurea; Platelet Aggregation Inhibitors; Platelet Count; Thrombocythemia, Essential	1992
Aspirin blocks 5-azacytidine- and hydroxyurea-induced changes in hemoglobin proportions in adult rats. European journal of pharmacology, 1991, Feb-07, Volume: 193, Issue:2 Topics: Age Factors; Animals; Aspirin; Azacitidine; Fetal Hemoglobin; Hydroxyurea; Male; Rats; Rats, Inbred Strains; Reference Values	1991
Prevention of recurrent thrombosis following liver transplantation for Budd-Chiari syndrome associated with myeloproliferative disorders: treatment with hydroxyurea and aspirin. Transplantation proceedings, 1991, Volume: 23, Issue:1 Pt 2 Topics: Adult; Aspirin; Budd-Chiari Syndrome; Female; Humans; Hydroxyurea; Liver Transplantation; Male; Myeloproliferative Disorders; Thrombosis	1991
Hydroxyurea-induced switching of hemoglobin proportions toward newborn values in normal adult rats is blocked by acetylsalicylic acid. Progress in clinical and biological research, 1989, Volume: 319 Topics: Aging; Anemia; Animals; Animals, Newborn; Aspirin; Fetal Hemoglobin; Hemoglobins; Hydroxyurea; Rats; Rats, Inbred Strains	1989
Amelioration of hydroxyurea-induced suppression of phagocytosis in human granulocytes by free radical scavengers. Scandinavian journal of haematology, 1985, Volume: 34, Issue:1 Topics: Antioxidants; Ascorbic Acid; Aspirin; Benzoates; Benzoic Acid; Catalase; Depression, Chemical; Free Radicals; Granulocytes; Humans; Hydroxyurea; Isoenzymes; Peroxidase; Peroxidases; Phagocytosis; Superoxide Dismutase; Vitamin E	1985
Comparison of teratogenic effects of aspirin and hydroxyurea in the Fischer 344 and Wistar strains. Journal of toxicology and environmental health, 1982, Volume: 10, Issue:2 Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Female; Hydroxyurea; Pregnancy; Rats; Rats, Inbred F344; Rats, Inbred Strains; Species Specificity; Teratogens	1982
Fever caused by hydroxyurea. Archives of internal medicine, 1981, Volume: 141, Issue:2 Topics: Aspirin; Female; Fever; Humans; Hydroxyurea; Middle Aged; Psoriasis; Recurrence	1981
Hydroxyurea in essential thrombocytosis. The New England journal of medicine, 1995, Sep-21, Volume: 333, Issue:12 Topics: Aspirin; Follow-Up Studies; Humans; Hydroxyurea; Platelet Aggregation Inhibitors; Thrombocytosis; Thrombosis	1995
Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells. American journal of veterinary research, 1995, Volume: 56, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Cell Line; Cell Survival; Dog Diseases; Dogs; Drug Screening Assays, Antitumor; Hydroxyurea; Indomethacin; Melanoma; Piroxicam; Sarcoma; Tumor Cells, Cultured; Tumor Stem Cell Assay	1995
[Recent trends in therapy of chronic myeloproliferative disorders]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Jul-10, Volume: 82, Issue:7 Topics: Alkylating Agents; Aspirin; Humans; Hydroxyurea; Interferons; Pipobroman; Prognosis; Thrombocythemia, Essential	1993
[Essential thrombocythemia and pregnancy]. Journal de gynecologie, obstetrique et biologie de la reproduction, 1994, Volume: 23, Issue:1 Topics: Aspirin; Female; Humans; Hydroxyurea; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Thrombocytosis	1994
Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma. American journal of ophthalmology, 1996, Volume: 121, Issue:6 Topics: Adrenergic beta-Antagonists; Antisickling Agents; Aspirin; Bone Marrow; Fluorescein Angiography; Fundus Oculi; Glaucoma, Neovascular; Humans; Hydroxyurea; Intraocular Pressure; Laser Coagulation; Male; Middle Aged; Neovascularization, Pathologic; Optic Disk; Platelet Aggregation Inhibitors; Platelet Count; Retinal Vein Occlusion; Thrombocythemia, Essential; Timolol	1996
Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls. Environmental health perspectives, 1996, Volume: 104, Issue:1 Topics: Animals; Arachidonic Acid; Aroclors; Aspirin; Cyclooxygenase Inhibitors; Hydroxyurea; In Vitro Techniques; Lipoxygenase Inhibitors; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Phospholipases A; Phospholipases A2; Polychlorinated Biphenyls; Quinacrine; Rats; Superoxides; Terpenes; Tetradecanoylphorbol Acetate	1996
The microvasculature in myeloproliferative disease. A study using retinal fluorescein angiography. Clinical and laboratory haematology, 1996, Volume: 18, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Allergens; Antineoplastic Agents; Arterial Occlusive Diseases; Aspirin; Busulfan; Eye Abnormalities; Female; Fluorescein Angiography; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Microcirculation; Middle Aged; Myeloproliferative Disorders; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia; Radionuclide Imaging; Retinal Hemorrhage; Retinal Vessels; Thrombocytosis; Visual Acuity	1996
[Essential thrombocythemia in pregnancy. A case report and general considerations]. Minerva ginecologica, 1997, Volume: 49, Issue:4 Topics: Adult; Aspirin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Infant, Newborn; Male; Platelet Aggregation Inhibitors; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Thrombocytosis; Time Factors	1997
The paradox of bleeding and thrombosis in thrombocythemia: is von Willebrand factor the link? Seminars in thrombosis and hemostasis, 1997, Volume: 23, Issue:4 Topics: Aged; Alkylating Agents; Aspirin; Erythromelalgia; Female; Fibrinolytic Agents; Hemorrhage; Hemorrhagic Disorders; Humans; Hydroxyurea; Ischemic Attack, Transient; Male; Middle Aged; Thrombocythemia, Essential; Thrombophilia; Thrombosis; von Willebrand Diseases; von Willebrand Factor	1997
Polycythemia vera: a retrospective and reprise. The Journal of laboratory and clinical medicine, 1997, Volume: 130, Issue:4 Topics: Aspirin; Blood Volume; Controlled Clinical Trials as Topic; Female; Hematocrit; History, 19th Century; History, 20th Century; Humans; Hydroxyurea; Male; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera	1997
Acute coronary disease in essential thrombocythemia and polycythemia vera. Journal of internal medicine, 1998, Volume: 244, Issue:1 Topics: Adult; Aged; Aging; Antisickling Agents; Aspirin; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Myocardial Infarction; Phlebotomy; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia Vera; Risk Factors; Thrombocythemia, Essential	1998
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis, 1998, Volume: 19, Issue:8 Topics: Animals; Anticarcinogenic Agents; Arachidonic Acid; Aspirin; Body Weight; Carcinogens; Drug Screening Assays, Antitumor; Female; Hydroxyurea; Indoles; Lipoxygenase Inhibitors; Lung Neoplasms; Mice; Mice, Inbred A; Neoplasms, Experimental; Nitrosamines	1998
Successful treatment of chronic urticaria with leukotriene antagonists. The Journal of allergy and clinical immunology, 1998, Volume: 102, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chronic Disease; Controlled Clinical Trials as Topic; Double-Blind Method; Humans; Hydroxyurea; Leukotriene Antagonists; Male; Urticaria	1998
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2000, Volume: 6, Issue:1 Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Hydroxyurea; Leukemia; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Outcome; Primary Myelofibrosis; Prospective Studies; Risk Factors; Splenectomy; Thrombocythemia, Essential; Venous Thrombosis; Warfarin	2000
Antileukotriene agents and aspirin-sensitive asthma: are we removing the second bassoonist or skating to where the puck is gonna be? Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 85, Issue:1 Topics: Aspirin; Asthma; Bronchial Spasm; Humans; Hydroxyurea; Leukotriene Antagonists; Therapeutic Equivalency	2000
Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 85, Issue:1 Topics: Administration, Oral; Aspirin; Asthma; Desensitization, Immunologic; Humans; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors	2000
Myeloproliferative syndromes. Current opinions from the European Hematology Association Working Group on Myeloproliferative Disorders. Pathologie-biologie, 2001, Volume: 49, Issue:2 Topics: Aspirin; Bone Marrow Examination; Clinical Trials as Topic; Clone Cells; Congresses as Topic; Disease Progression; Europe; Female; Growth Substances; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hydroxyurea; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myeloproliferative Disorders; Platelet Count; Polycythemia Vera; Prospective Studies	2001
Medical management of a large aortic thrombus in a young woman with essential thrombocythemia. Mayo Clinic proceedings, 2001, Volume: 76, Issue:4 Topics: Aorta, Abdominal; Aortic Diseases; Aspirin; Biopsy, Needle; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxyurea; Middle Aged; Severity of Illness Index; Thrombocytosis; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome	2001
Polycythemia vera in a 12-year-old girl: a case report. Pediatric hematology and oncology, 2002, Volume: 19, Issue:4 Topics: Aspirin; Child; Drug Therapy, Combination; Female; Hemoglobins; Humans; Hydroxyurea; Leukocyte Count; Phlebotomy; Platelet Count; Polycythemia Vera; Splenomegaly	2002
Four pregnancies in two patients with essential thrombocythaemia--a case report. Annals of the Academy of Medicine, Singapore, 2002, Volume: 31, Issue:3 Topics: Adult; Aspirin; Combined Modality Therapy; Cyclooxygenase Inhibitors; Female; Fetal Death; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Patient Care Team; Platelet Count; Plateletpheresis; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Prenatal Care; Thrombocythemia, Essential	2002
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. Circulation, 2004, Sep-07, Volume: 110, Issue:10 Topics: Acetylcholine; Animals; Aorta; Aspirin; Blood Pressure; Celecoxib; Cyclooxygenase 2 Inhibitors; Endothelium, Vascular; Hydroxyurea; Lipoxins; Lipoxygenase Inhibitors; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroarginine; Oligopeptides; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Lipoxin; Sulfonamides; Vascular Resistance; Vasodilation; Vasodilator Agents	2004
[Polycythemia vera and pregnancy]. Journal de gynecologie, obstetrique et biologie de la reproduction, 2004, Volume: 33, Issue:6 Pt 1 Topics: Adult; Antisickling Agents; Aspirin; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Polycythemia; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome	2004
When and how to treat essential thrombocythemia. The New England journal of medicine, 2005, Jul-07, Volume: 353, Issue:1 Topics: Antineoplastic Agents; Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Platelet Aggregation Inhibitors; Primary Myelofibrosis; Quinazolines; Risk Factors; Thrombocythemia, Essential; Thrombosis	2005
Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera. Leukemia research, 2007, Volume: 31, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Aspirin; Bone Marrow; Diagnosis, Differential; DNA; Female; Genetic Markers; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Mutation; Polycythemia; Polycythemia Vera; RNA; Treatment Outcome	2007
An unusual case of toe ulceration. Vascular medicine (London, England), 2006, Volume: 11, Issue:1 Topics: Adult; Aspirin; Erythropoietin; Fibrinolytic Agents; Foot Ulcer; Hematocrit; Humans; Hydroxyurea; Male; Phlebotomy; Platelet Count; Polycythemia Vera; Thrombocytosis; Toes	2006
Cerebral venous sinus thrombosis associated with essential thrombocytosis in a pediatric patient. Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:3 Topics: Adolescent; Anticoagulants; Aspirin; Bone Marrow; Follow-Up Studies; Humans; Hydroxyurea; Magnetic Resonance Angiography; Male; Mucositis; Platelet Count; Sensitivity and Specificity; Sinus Thrombosis, Intracranial; Thrombocytosis; Treatment Outcome; Warfarin	2007
Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies. Pediatric blood & cancer, 2008, Volume: 50, Issue:4 Topics: Aspirin; Bone and Bones; Child, Preschool; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Male; Mothers; Pedigree; Platelet Count; Thrombocythemia, Essential; Thrombopoietin	2008
[Case of erythromelalgia due to essential thrombocythemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5 Topics: Aged; Aspirin; Debridement; Diagnosis, Differential; Erythromelalgia; Female; Humans; Hydroxyurea; Thrombocythemia, Essential; Treatment Outcome	2007
Practical approach to treating essential thrombocythaemia: case studies. European journal of haematology. Supplementum, 2007, Issue:68 Topics: Adult; Aspirin; Disease Management; Female; Humans; Hydroxyurea; Interferon-alpha; Leg Ulcer; Male; Middle Aged; Pipobroman; Platelet Count; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Thrombocythemia, Essential; Warfarin	2007
Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica, 2008, Volume: 93, Issue:3 Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Hydroxyurea; Janus Kinase 2; Multicenter Studies as Topic; Phlebotomy; Polycythemia Vera; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocythemia, Essential; Thrombophilia; Thrombosis; Ticlopidine; Venous Thrombosis	2008
[Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2008, Volume: 36, Issue:1 Topics: Adult; Anticoagulants; Antisickling Agents; Aspirin; Coronary Angiography; Diagnosis, Differential; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Polycythemia Vera; Thrombocytosis; Thrombolytic Therapy	2008
Essential thrombocythemia: a case of acute ST-segment elevation myocardial infarction in a young female. Clinical cardiology, 2009, Volume: 32, Issue:2 Topics: Adult; Age Factors; Antisickling Agents; Aspirin; Clopidogrel; Coronary Angiography; Female; Fibrinolytic Agents; Heparin; Humans; Hydroxyurea; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombocythemia, Essential; Ticlopidine; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2009
JAK2V617F mutation-positive childhood essential thrombocythemia associated with cerebral venous sinus thrombosis. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:9 Topics: Aspirin; Child; Clone Cells; Cytotoxins; Diagnosis, Differential; Female; Headache; Humans; Hydroxyurea; Janus Kinase 2; Nausea; Platelet Aggregation Inhibitors; Recurrence; Sinus Thrombosis, Intracranial; Supratentorial Neoplasms; Thrombocythemia, Essential; Thrombophilia	2009
Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations. American journal of hematology, 2009, Volume: 84, Issue:10 Topics: Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Interferon Type I; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recombinant Proteins; Thrombocythemia, Essential	2009
Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis. Clinical therapeutics, 2009, Volume: 31, Issue:11 Topics: Aged; Aspirin; Blood Cell Count; Blood Chemical Analysis; Blood Transfusion; Drug Resistance; Erythropoietin; Fatal Outcome; Female; Humans; Hydroxyurea; Jehovah's Witnesses; Kidney Failure, Chronic; Kidney Function Tests; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Recombinant Proteins; Renal Dialysis; Thrombocythemia, Essential	2009
Treatment outcome in a cohort of young patients with polycythemia vera. Internal and emergency medicine, 2010, Volume: 5, Issue:5 Topics: Adult; Antineoplastic Agents; Aspirin; Cohort Studies; Combined Modality Therapy; Disease Progression; Female; Fibrinolytic Agents; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Phlebotomy; Polycythemia Vera; Retrospective Studies; Thrombosis; Young Adult	2010
Acute myocardial infarction in a patient with chronic myelocytic leukemia during chemotherapy with hydroxyurea. Herz, 2010, Volume: 35, Issue:6 Topics: Angioplasty, Balloon, Coronary; Anterior Wall Myocardial Infarction; Antineoplastic Agents; Aspirin; Cineangiography; Combined Modality Therapy; Coronary Angiography; Coronary Thrombosis; Dose-Response Relationship, Drug; Heparin; Humans; Hydroxyurea; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Platelet Aggregation Inhibitors; Retreatment; Thrombocytopenia; Ultrasonography, Interventional	2010
Red cells playing as activated platelets in thalassemia intermedia. Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:10 Topics: Aspirin; beta-Thalassemia; Blood Platelets; Erythrocytes; Hematology; Hemoglobins; Humans; Hydroxyurea; Risk; Risk Factors; Splenectomy; Thrombosis	2010
Pruritic indurated plaques on the legs of a 62-year-old woman--quiz case. Polycythemia vera (PCV). Archives of dermatology, 2011, Volume: 147, Issue:1 Topics: Aspirin; Biopsy; Female; Humans; Hydroxyurea; Janus Kinase 2; Leg; Middle Aged; Point Mutation; Polycythemia Vera; Pruritus; Skin	2011
Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia. Rheumatology international, 2012, Volume: 32, Issue:1 Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Comorbidity; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Mutation; Platelet Count; Thrombocythemia, Essential; Treatment Outcome	2012
Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology. Transplantation, 2011, Aug-15, Volume: 92, Issue:3 Topics: Adolescent; Adult; Anticoagulants; Aspirin; Budd-Chiari Syndrome; Child; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Survival; Hepatic Artery; Humans; Hydroxyurea; Liver Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Portal Vein; Postoperative Complications; Thrombosis; Warfarin; Young Adult	2011
Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:6 Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Platelets; Collagen; Epinephrine; Female; Greece; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Longitudinal Studies; Male; Middle Aged; Platelet Aggregation; Platelet Count; Platelet Function Tests; Point Mutation; Regression Analysis; Thrombocythemia, Essential; von Willebrand Factor	2011
Anticoagulant-resistant thrombophilia in a patient with polycythemia vera: a case report. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011, Volume: 22, Issue:8 Topics: Aged; Anticoagulants; Aspirin; Factor Xa; Factor Xa Inhibitors; Fatal Outcome; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Male; Mechanical Thrombolysis; Phlebotomy; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia Vera; Thrombophilia; Thrombosis; United States	2011
Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection. American journal of hematology, 2012, Volume: 87, Issue:3 Topics: Alkylating Agents; Anticoagulants; Aspirin; CD146 Antigen; Drug Therapy, Combination; E-Selectin; Endothelial Cells; Endothelium, Vascular; Female; Flow Cytometry; Follow-Up Studies; Humans; Hydroxyurea; Immunomagnetic Separation; Immunophenotyping; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Neovascularization, Pathologic; Thrombocythemia, Essential	2012
How to manage children and young adults with myeloproliferative neoplasms. Leukemia, 2012, Volume: 26, Issue:7 Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiviral Agents; Aspirin; Disease Management; Female; Humans; Hydroxyurea; Interferon-alpha; Male; Myeloproliferative Disorders; Practice Guidelines as Topic; Risk Assessment; Thrombosis	2012
Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea. International journal of hematology, 2012, Volume: 96, Issue:6 Topics: Aspirin; Asymptomatic Diseases; Bone Marrow; Child; Child, Preschool; Female; Headache; Humans; Hydroxyurea; Janus Kinase 2; Male; Mutation, Missense; Platelet Count; Point Mutation; Remission Induction; Thrombocythemia, Essential	2012
Hemichorea in a patient with JAK2V617F blood cells. Blood, 2013, Feb-14, Volume: 121, Issue:7 Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Aspirin; Chorea; Female; Humans; Hydroxyurea; Janus Kinase 2; Mutation, Missense; Myeloproliferative Disorders; Phlebotomy	2013
Dysplasia of all granulocyte lineages in myelodysplastic evolution of essential thrombocythemia. American journal of hematology, 2013, Volume: 88, Issue:5 Topics: Aged; Amino Acid Substitution; Antineoplastic Agents; Aspirin; Bone Marrow; Cell Lineage; Cell Transformation, Neoplastic; Granulocytes; Humans; Hydroxyurea; Janus Kinase 2; Male; Myelodysplastic Syndromes; Platelet Aggregation Inhibitors; Thrombocythemia, Essential; Treatment Outcome	2013
The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:11 Topics: Aspirin; Fibrinolytic Agents; Humans; Hydroxyurea; Interferon-alpha; Platelet Aggregation Inhibitors; Quinazolines; Risk Assessment; Thrombocythemia, Essential	2013
Cutaneous involvement by post-polycythemia vera myelofibrosis. American journal of hematology, 2014, Volume: 89, Issue:4 Topics: Aged; Aspirin; Biopsy; Cell Lineage; Disease Progression; Drug Therapy, Combination; Fibrosis; Hematopoiesis, Extramedullary; Humans; Hydroxyurea; Male; Polycythemia Vera; Primary Myelofibrosis; Skin; Splenomegaly	2014
[A preschool child with primary thrombocytosis]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2013, Volume: 51, Issue:7 Topics: Aspirin; Blood Cell Count; Blood Platelets; C-Reactive Protein; Child, Preschool; Diagnosis, Differential; Female; Humans; Hydroxyurea; Interferons; Platelet Count; Thrombocythemia, Essential	2013
The thrombotic events in polycythemia vera patients may be related to increased oxidative stress. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2014, Volume: 23, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Aspirin; Body Mass Index; Bone Marrow; Case-Control Studies; Female; Humans; Hydroxyurea; Lipids; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Phlebotomy; Polycythemia Vera; Thrombosis	2014
Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis. American journal of hematology, 2015, Volume: 90, Issue:5 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Austria; Female; Humans; Hydroxyurea; International Cooperation; Italy; Male; Middle Aged; Polycythemia Vera; Thrombosis; Time Factors; Treatment Outcome; United States	2015
New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera. American journal of hematology, 2015, Volume: 90, Issue:8 Topics: Age Factors; Aged; Aspirin; Drug Administration Schedule; Enzyme Inhibitors; Fibrinolytic Agents; Humans; Hydroxyurea; Janus Kinase 2; Middle Aged; Mutation; Patient Selection; Phlebotomy; Polycythemia Vera; Risk; Risk Assessment; Thrombocythemia, Essential; Thrombosis	2015
Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. Journal of thrombosis and haemostasis : JTH, 2015, Volume: 13, Issue:7 Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Aged; Amyloid Precursor Protein Secretases; Aspirin; Biomarkers; Blood Platelets; Case-Control Studies; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Hydrolysis; Hydroxyurea; Male; Membrane Proteins; Middle Aged; Multivariate Analysis; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Count; Thrombocythemia, Essential; von Willebrand Factor	2015
[Polycythemia vera: the disadvantages of overproduction]. MMW Fortschritte der Medizin, 2015, Apr-30, Volume: 157, Issue:8 Topics: Aged; Aspirin; Bloodletting; Diagnosis, Differential; Female; Hematocrit; Humans; Hydroxyurea; Interferons; Male; Middle Aged; Nitriles; Polycythemia Vera; Pyrazoles; Pyrimidines; Thromboembolism	2015
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations. Blood, 2015, Dec-10, Volume: 126, Issue:24 Topics: Adolescent; Adult; Alleles; Aspirin; Calreticulin; Clonal Evolution; Clone Cells; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; Female; Follow-Up Studies; Genes, p53; Humans; Hydroxyurea; Interferon-alpha; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Off-Label Use; Polyethylene Glycols; Proto-Oncogene Proteins; Recombinant Proteins; Remission Induction; Repressor Proteins; Thrombocythemia, Essential; Young Adult	2015
Acute pancreatitis as a side effect of anagrelide hydrochloride hydrate: a case report. Annals of hematology, 2016, Volume: 95, Issue:11 Topics: Abdominal Pain; Acute Disease; Aged; Aspirin; Drug Substitution; Female; Humans; Hydroxyurea; Janus Kinase 2; Mutation; Pancreatitis; Phosphodiesterase Inhibitors; Quinazolines; Thrombocythemia, Essential	2016
Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin. European journal of haematology, 2017, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hungary; Hydroxyurea; Male; Middle Aged; Platelet Aggregation Inhibitors; Quinazolines; Risk; Thrombocythemia, Essential; Thrombosis	2017
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. American journal of hematology, 2017, Volume: 92, Issue:1 Topics: Aspirin; Calreticulin; Diagnosis, Differential; Erythropoietin; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Polycythemia Vera; Primary Myelofibrosis; Receptors, Thrombopoietin; Risk Assessment; Thrombocythemia, Essential; Thrombocytosis	2017
Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia. Translational research : the journal of laboratory and clinical medicine, 2017, Volume: 184 Topics: Adrenomedullin; Aged; Aspirin; Blood Platelets; Case-Control Studies; Cell-Derived Microparticles; Endothelin-1; Endothelium, Vascular; Female; Humans; Hydroxyurea; Male; Middle Aged; Nitric Oxide; Quinazolines; Retrospective Studies; Thrombocythemia, Essential	2017
Frontiers in cellular and infection microbiology, 2017, Volume: 7 Topics: Animals; Aorta; Arachidonic Acid; Aspirin; Cell Adhesion Molecules; DNA, Bacterial; Endothelial Cells; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Hydroxyurea; Inflammation; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred BALB C; Monocytes; Mutation; Phospholipases A2; Recombinant Proteins; Signal Transduction; Streptococcus pyogenes; THP-1 Cells; Vascular Cell Adhesion Molecule-1	2017
JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN). International journal of hematology, 2017, Volume: 106, Issue:5 Topics: Algorithms; Aniline Compounds; Antineoplastic Agents; Aspirin; Blood Transfusion; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Imidazoles; Japan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myeloproliferative Disorders; Nitriles; Phlebotomy; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyridazines; Pyrimidines; Quinazolines; Quinolines; Risk	2017
Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. American journal of hematology, 2019, Volume: 94, Issue:1 Topics: Adult; Aspirin; Bone Marrow; Busulfan; Disease Management; Disease Progression; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Mutation; Phlebotomy; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis; Thrombocythemia, Essential; Thrombosis; Young Adult	2019
Recurrent Stroke in a Ghanaian Patient With Polycythemia. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019, Volume: 28, Issue:3 Topics: Aphasia, Broca; Aspirin; Clopidogrel; Ghana; Humans; Hydroxyurea; Infarction, Middle Cerebral Artery; Male; Medication Adherence; Middle Aged; Paresis; Phlebotomy; Platelet Aggregation Inhibitors; Polycythemia; Recurrence; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome	2019
Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea-induced methemoglobinemia. American journal of hematology, 2019, Volume: 94, Issue:8 Topics: Aspirin; Brain Ischemia; Child; Female; Hemoglobinopathies; Hemoglobins, Abnormal; Humans; Hydroxyurea; Methemoglobinemia; Moyamoya Disease; Treatment Outcome	2019
Effect of Zileuton Treatment on Sinonasal Quality of Life in Patients with Aspirin-Exacerbated Respiratory Disease. American journal of rhinology & allergy, 2019, Volume: 33, Issue:6 Topics: Adult; Aged; Allergens; Anti-Asthmatic Agents; Arachidonate 5-Lipoxygenase; Aspirin; Asthma, Aspirin-Induced; Chronic Disease; Female; Humans; Hydroxyurea; Male; Middle Aged; Quality of Life; Retrospective Studies; Sinusitis; Surveys and Questionnaires; Treatment Outcome	2019
Limb gangrene: The first sign of essential thrombocythemia. The Indian journal of medical research, 2020, Volume: 151, Issue:4 Topics: Aged, 80 and over; Amputation, Surgical; Aspirin; Female; Gangrene; Humans; Hydroxyurea; Leg; Platelet Count; Thrombocythemia, Essential; Thrombocytosis	2020
Anagrelide influences thrombotic risk, and prolongs progression-free and overall survival in essential thrombocythaemia vs hydroxyurea plus aspirin. European journal of haematology, 2020, Volume: 105, Issue:4 Topics: Aspirin; Drug Therapy, Combination; Health Care Surveys; Humans; Hungary; Hydroxyurea; Quinazolines; Registries; Thrombocythemia, Essential; Thrombosis; Treatment Outcome	2020
[Recent advances in polycythemia vera treatment]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2020, Volume: 61, Issue:9 Topics: Aspirin; Clinical Trials as Topic; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Polycythemia Vera; Thrombosis	2020
Multiple aortic thrombi in essential thrombocythaemia. British journal of haematology, 2021, Volume: 193, Issue:5 Topics: Aged; Aorta, Abdominal; Aspirin; Cefazolin; Echocardiography; Heparin; Humans; Hydroxyurea; Male; Staphylococcal Infections; Staphylococcus; Thrombocythemia, Essential; Thrombosis; Tomography, X-Ray Computed	2021
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis. American journal of hematology, 2021, 06-01, Volume: 96, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Bone Marrow; Calreticulin; Dexamethasone; Humans; Hydroxyurea; Lenalidomide; Male; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Osteolysis; Primary Myelofibrosis; Remission Induction; Risk Factors; Sequence Deletion; Stomatitis, Aphthous; Thrombocythemia, Essential	2021
Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms. Annals of hematology, 2021, Volume: 100, Issue:10 Topics: Adolescent; Adult; Antineoplastic Agents; Aspirin; Child; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Hydroxyurea; Leukemia; Male; Neoplasms, Second Primary; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Thromboembolism; Young Adult	2021
Cytoreductive treatment in real life: a chart review analysis on 1440 patients with polycythemia vera. Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:10 Topics: Aged; Aspirin; Cytoreduction Surgical Procedures; Humans; Hydroxyurea; Phlebotomy; Polycythemia Vera	2022
Hemorrhages in Polycythemia Vera and Essential Thrombocythemia: Epidemiology, Description, and Risk Factors-Learnings from a Large Cohort. Thrombosis and haemostasis, 2022, Volume: 122, Issue:10 Topics: Aspirin; Hemorrhage; Humans; Hydroxyurea; Male; Polycythemia Vera; Risk Factors; Thrombocythemia, Essential	2022
Cytoreductive treatment and association with platelet function and maturity in patients with essential thrombocythaemia. British journal of haematology, 2022, Volume: 198, Issue:4 Topics: Aspirin; Blood Platelets; Humans; Hydroxyurea; Platelet Aggregation; Platelet Function Tests; Thrombocythemia, Essential	2022
Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter? Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023, 02-28, Volume: 40, Issue:1 Topics: Aspirin; Blood Platelets; Humans; Hydroxyurea; Myeloproliferative Disorders; Neoplasms	2023